Imaging biomarkers in preclinical studies on brain tumors

Karavallil A. Smitha, Arun kumar Gupta, Ramapurath S. Jayasree, Total magnitude of diffusion tensor imaging as an effective tool for the differentiation of glioma. European Journal of Radiology. ,vol. 82, pp. 857- 861 ,(2013) , 10.1016/J.EJRAD.2012.12.027

Brian D. Ross, Paul E. McKeever, Thomas L. Chenevert, Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clinical Cancer Research. ,vol. 3, pp. 1457- 1466 ,(1997)

Barbara Krammer, Kristjan Plaetzer, ALA and its clinical impact, from bench to bedside Photochem. Photobiol. Sci.. ,vol. 7, pp. 283- 289 ,(2008) , 10.1039/B712847A

Benjamin M Ellingson, Mark G Malkin, Scott D Rand, Jennifer M Connelly, Carolyn Quinsey, Pete S LaViolette, Devyani P Bedekar, Kathleen M Schmainda, None, Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. Journal of Magnetic Resonance Imaging. ,vol. 31, pp. 538- 548 ,(2010) , 10.1002/JMRI.22068

A. Gregory Sorensen, Tracy T. Batchelor, Wei-Ting Zhang, Poe-Jou Chen, Priscilla Yeo, Meiyun Wang, Dominique Jennings, Patrick Y. Wen, Johanna Lahdenranta, Marek Ancukiewicz, Emmanuelle di Tomaso, Dan G. Duda, Rakesh K. Jain, A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. Cancer Research. ,vol. 69, pp. 5296- 5300 ,(2009) , 10.1158/0008-5472.CAN-09-0814

G. Allan Johnson, Gary P. Cofer, Sally L. Gewalt, Laurence W. Hedlund, Morphologic phenotyping with MR microscopy: the visible mouse. Radiology. ,vol. 222, pp. 789- 793 ,(2002) , 10.1148/RADIOL.2223010531

Aurélien Corroyer-Dulmont, Elodie A. Pérès, Edwige Petit, Jean-Sébastien Guillamo, Nathalie Varoqueaux, Simon Roussel, Jérôme Toutain, Didier Divoux, Eric T. MacKenzie, Jérôme Delamare, Méziane Ibazizène, Myriam Lecocq, Andréas H. Jacobs, Louisa Barré, Myriam Bernaudin, Samuel Valable, Detection of glioblastoma response to temozolomide combined with bevacizumab based on µMRI and µPET imaging reveals [18F]-fluoro-l-thymidine as an early and robust predictive marker for treatment efficacy Neuro-oncology. ,vol. 15, pp. 41- 56 ,(2013) , 10.1093/NEUONC/NOS260

L. L. Muldoon, S. Gahramanov, X. Li, D. J. Marshall, D. F. Kraemer, E. A. Neuwelt, Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models. Neuro-oncology. ,vol. 13, pp. 51- 60 ,(2011) , 10.1093/NEUONC/NOQ150

Stefan Zwick, Ralph Strecker, Valerji Kiselev, Peter Gall, Jochen Huppert, Moritz Palmowski, Wiltrud Lederle, Eva C. Woenne, Arne Hengerer, Matthias Taupitz, Wolfhard Semmler, Fabian Kiessling, Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging. Journal of Magnetic Resonance Imaging. ,vol. 29, pp. 1125- 1133 ,(2009) , 10.1002/JMRI.21710

Olivier L Chinot, Wolfgang Wick, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Antoine F Carpentier, Khe Hoang-Xuan, Petr Kavan, Dana Cernea, Alba A Brandes, Magalie Hilton, Lauren Abrey, Timothy Cloughesy, None, Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma The New England Journal of Medicine. ,vol. 370, pp. 709- 722 ,(2014) , 10.1056/NEJMOA1308345